AIM Therapeutics Inc.

For profit

Also known as: Ningbo Rongan Biological Pharmaceutical Co. Ltd | Ningbo Rongan Biological Pharmaceutical Co. Ltd. | Ningbo Rongan Biological Pharmaceutical Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 1, 2012

Last known activity

Jul 31, 2025

Defunct as of Dec 31, 2017

Timeline

2000s

Jun 1, 2005
AIM Therapeutics Inc.— Founded

2010s

Dec 31, 2017
AIM Therapeutics Inc.— Defunct

Drugs by trial phase (11 distinct, 12 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Other trials (3 own, 0 via acquisition)

Indications

Studied for

Asthma

Recent trials (12)

NCT07028801Lead sponsorPhase 3Jul 31, 2025
NCT07021703Lead sponsorPhase 1May 23, 2025
NCT05939648CollaboratorPhase 2Oct 9, 2023
NCT05812014CollaboratorPhase 3Mar 25, 2023
NCT05599802CollaboratorPhase 1Feb 28, 2023
NCT05549206CollaboratorN/AFeb 28, 2023
NCT05682638CollaboratorPhase 3Jan 30, 2023
NCT05745545CollaboratorN/AJan 4, 2023
NCT05547243CollaboratorN/ASep 26, 2022
NCT05550142CollaboratorN/ASep 16, 2022
NCT05547256CollaboratorN/ASep 13, 2022
NCT01501942Lead sponsorPhase 2Feb 1, 2012

Details

Founded: Toronto, ON, CA Jun 1, 2005
Last known activity: Jul 31, 2025